About this FactMed analysis covering adverse side effect reports of CAPECITABINE patients who developed ADHESION.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking CAPECITABINE reported ADHESION to the FDA. A total of 15007 CAPECITABINE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between CAPECITABINE and ADHESION. In doing so, we compare CAPECITABINE with other drugs that cause ADHESION, to help you evaluate whether or not CAPECITABINE causes ADHESION. Likewise, this page shows the most highly-reported side effects of CAPECITABINE, so you can see if ADHESION ranks among CAPECITABINE's most well-known side effects.
Summary Statistics
Reports of CAPECITABINE causing ADHESION: 2
Reports of any side effect of CAPECITABINE : 15007
Percentage of CAPECITABINE patients where ADHESION is a reported side effect: 0.0133%

FDA reports of any drug causing ADHESION : 955
Average percentage for all medicated patients where ADHESION is reported as a complication: 0.0060%

Physician opinion on CAPECITABINE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing CAPECITABINE:
BREAST CANCER ( 1674 patients )
COLORECTAL CANCER ( 968 patients )
GASTRIC CANCER ( 808 patients )
COLON CANCER ( 688 patients )
RECTAL CANCER ( 529 patients )
BREAST CANCER METASTATIC ( 482 patients )
DRUG USE FOR UNKNOWN INDICATION ( 474 patients )
COLORECTAL CANCER METASTATIC ( 346 patients )
GASTROOESOPHAGEAL CANCER ( 220 patients )
PANCREATIC CARCINOMA ( 143 patients )
METASTATIC GASTRIC CANCER ( 134 patients )
OESOPHAGEAL CARCINOMA ( 105 patients )
COLON CANCER METASTATIC ( 95 patients )
GASTROINTESTINAL CARCINOMA ( 65 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 62 patients )
ADENOCARCINOMA PANCREAS ( 45 patients )
RECTAL CANCER METASTATIC ( 40 patients )
HEPATIC NEOPLASM MALIGNANT ( 33 patients )
CHEMOTHERAPY ( 32 patients )
ADENOCARCINOMA ( 31 patients )
OESOPHAGEAL ADENOCARCINOMA ( 30 patients )
NEOPLASM MALIGNANT ( 27 patients )
COLON CANCER STAGE III ( 26 patients )
PANCREATIC CARCINOMA METASTATIC ( 25 patients )
BILE DUCT CANCER ( 25 patients )
BREAST CANCER RECURRENT ( 24 patients )
METASTATIC RENAL CELL CARCINOMA ( 22 patients )
OESOPHAGEAL CANCER METASTATIC ( 21 patients )
BLADDER CANCER ( 21 patients )
RENAL CELL CARCINOMA STAGE UNSPECIFIED ( 21 patients )
METASTATIC NEOPLASM ( 20 patients )
NEOPLASM ( 17 patients )
OVARIAN CANCER ( 16 patients )
METASTASES TO LIVER ( 16 patients )
HEAD AND NECK CANCER ( 15 patients )
NEUROENDOCRINE CARCINOMA ( 15 patients )
PROSTATE CANCER ( 15 patients )
NON-SMALL CELL LUNG CANCER ( 13 patients )
BRAIN STEM GLIOMA ( 12 patients )
GLIOMA ( 12 patients )
RENAL CELL CARCINOMA ( 12 patients )
GALLBLADDER CANCER ( 10 patients )
COLORECTAL CANCER STAGE IV ( 9 patients )
GALLBLADDER CANCER METASTATIC ( 8 patients )
METASTASIS ( 8 patients )
BILIARY CANCER METASTATIC ( 7 patients )
NASOPHARYNGEAL CANCER ( 7 patients )
BREAST NEOPLASM ( 7 patients )
COLON CANCER STAGE II ( 6 patients )
LARGE INTESTINE CARCINOMA ( 6 patients )
COLON CANCER STAGE IV ( 5 patients )
MALIGNANT PERITONEAL NEOPLASM ( 5 patients )
METASTASES TO BONE ( 5 patients )
SALIVARY GLAND CANCER ( 5 patients )
ANAL CANCER ( 5 patients )
DISEASE PROGRESSION ( 5 patients )
GASTRIC CANCER STAGE IV ( 4 patients )
NEUROENDOCRINE TUMOUR ( 4 patients )
CERVIX CARCINOMA ( 4 patients )
SARCOMA ( 4 patients )
LUNG ADENOCARCINOMA METASTATIC ( 4 patients )
SQUAMOUS CELL CARCINOMA ( 4 patients )
METASTASES TO CENTRAL NERVOUS SYSTEM ( 4 patients )
METASTASES TO LUNG ( 4 patients )
METASTASES TO RECTUM ( 3 patients )
LYMPHADENOPATHY ( 3 patients )
RECTOSIGMOID CANCER ( 3 patients )
ADENOID CYSTIC CARCINOMA ( 3 patients )
RENAL CANCER METASTATIC ( 3 patients )
BREAST CANCER STAGE IV ( 3 patients )
PROSTATE CANCER METASTATIC ( 3 patients )
METASTASES TO PERITONEUM ( 3 patients )
OESOPHAGEAL SQUAMOUS CELL CARCINOMA ( 3 patients )
LUNG NEOPLASM MALIGNANT ( 3 patients )
OVARIAN CANCER METASTATIC ( 3 patients )
RECTAL NEOPLASM ( 3 patients )
RENAL CANCER ( 3 patients )
ADRENAL GLAND CANCER METASTATIC ( 3 patients )
POROCARCINOMA ( 3 patients )
CARCINOMA ( 3 patients )
OESOPHAGEAL SQUAMOUS CELL CARCINOMA RECURRENT ( 2 patients )
SMALL INTESTINE CARCINOMA ( 2 patients )
RECTAL CANCER STAGE II ( 2 patients )
LUNG CANCER METASTATIC ( 2 patients )
RECTAL CANCER STAGE IV ( 2 patients )
THYROID CANCER METASTATIC ( 2 patients )
PANCREATIC CARCINOMA STAGE IV ( 2 patients )
ANAL CANCER METASTATIC ( 2 patients )
METASTASES TO EYE ( 2 patients )
COLON CANCER RECURRENT ( 2 patients )
BRAIN CANCER METASTATIC ( 2 patients )
RECTAL CANCER STAGE III ( 2 patients )
THYMOMA MALIGNANT ( 2 patients )
MALIGNANT HEPATOBILIARY NEOPLASM ( 2 patients )
GASTROINTESTINAL NEOPLASM ( 2 patients )
COLORECTAL CANCER STAGE III ( 2 patients )
BREAST CANCER STAGE III ( 2 patients )
PROPHYLAXIS ( 2 patients )
HEPATIC CANCER METASTATIC ( 2 patients )
ANGIOSARCOMA ( 2 patients )
METASTASES TO LARGE INTESTINE ( 2 patients )
INFLAMMATORY CARCINOMA OF BREAST STAGE III ( 1 patients )
SALIVARY GLAND NEOPLASM ( 1 patients )
BIOPSY ( 1 patients )
LIVER DISORDER ( 1 patients )
BONE CANCER METASTATIC ( 1 patients )
SQUAMOUS CELL CARCINOMA OF THE CERVIX ( 1 patients )
BRAIN NEOPLASM MALIGNANT ( 1 patients )
ADENOCARCINOMA OF THE CERVIX ( 1 patients )
VULVAL CANCER STAGE IV ( 1 patients )
NEOPLASM PROPHYLAXIS ( 1 patients )
ADRENOCORTICAL CARCINOMA ( 1 patients )
RENAL CELL CARCINOMA STAGE IV ( 1 patients )
PROPHYLAXIS OF NAUSEA AND VOMITING ( 1 patients )
CARCINOID TUMOUR ( 1 patients )
HEPATIC CANCER STAGE IV ( 1 patients )
NON-SMALL CELL LUNG CANCER METASTATIC ( 1 patients )
RESPIRATORY DISORDER ( 1 patients )
BASAL CELL CARCINOMA ( 1 patients )
ENDOCRINE NEOPLASM MALIGNANT ( 1 patients )
HEPATIC NEOPLASM MALIGNANT NON-RESECTABLE ( 1 patients )
ENDOMETRIAL CANCER METASTATIC ( 1 patients )
RECTAL CANCER RECURRENT ( 1 patients )
ORGAN TRANSPLANT ( 1 patients )
GASTRIC CANCER RECURRENT ( 1 patients )
GASTROINTESTINAL CANCER METASTATIC ( 1 patients )
VASCULAR OPERATION ( 1 patients )
MASS ( 1 patients )
ENDOCRINE NEOPLASM ( 1 patients )
RETROPERITONEAL CANCER ( 1 patients )
ENDOMETRIAL CANCER ( 1 patients )
PSEUDOMYXOMA PERITONEI ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with ADHESION:

FOSAMAX (219 patients)
VIOXX (200 patients)
HUMIRA (129 patients)
REMICADE (102 patients)
PEGASYS (82 patients)
ACCUTANE (70 patients)
LIPITOR (58 patients)
NEURONTIN (55 patients)
ASPIRIN (46 patients)
AVONEX (45 patients)
SYNTHROID (44 patients)
PRILOSEC (42 patients)
LORAZEPAM (41 patients)
COPEGUS (40 patients)
FOLIC ACID (40 patients)
VITAMIN E (39 patients)
PAXIL (38 patients)
METHOTREXATE (37 patients)
CELEBREX (37 patients)
DIANEAL (37 patients)
PREMARIN (37 patients)
LISINOPRIL (32 patients)
HYDROCHLOROTHIAZIDE (31 patients)
LYRICA (30 patients)
FLOVENT (30 patients)
XANAX (28 patients)
LIORESAL (28 patients)
NORVASC (27 patients)
PREDNISONE (27 patients)
IBUPROFEN (27 patients)
ACTONEL (26 patients)
ALBUTEROL (26 patients)
[THERAPY UNSPECIFIED] (26 patients)
CALCIUM (UNSPECIFIED) (26 patients)
DIGOXIN (25 patients)
AMBIEN (25 patients)
PROTONIX (25 patients)
FUROSEMIDE (24 patients)
ATENOLOL (24 patients)
LASIX (23 patients)
OXYCONTIN (23 patients)
NEXIUM (23 patients)
FLEXERIL (22 patients)
ACETAMINOPHEN (21 patients)
FOSAMAX PLUS D (21 patients)
ZANTAC (21 patients)
ZOLOFT (21 patients)
EVISTA (21 patients)
VITAMIN D (21 patients)
CIPRO (20 patients)
LEVOTHYROXINE SODIUM (20 patients)
FORTEO (19 patients)
PREDNISONE TAB (19 patients)
LANOXIN (19 patients)
LEXAPRO (18 patients)
ACIPHEX (18 patients)
LORTAB (18 patients)
COUMADIN (18 patients)
OMEPRAZOLE (18 patients)
FLUOROURACIL (18 patients)
VERAPAMIL (17 patients)
VITAMINS (UNSPECIFIED) (17 patients)
PERCOCET (17 patients)
HYDROCODONE BITARTRATE (17 patients)
TRAZODONE HYDROCHLORIDE (17 patients)
CLARITIN (17 patients)
CLONAZEPAM (17 patients)
MULTI-VITAMIN (17 patients)
MYCOPHENOLATE MOFETIL (16 patients)
DETROL LA (16 patients)
ACETAMINOPHEN AND HYDROCODONE BITARTRATE (16 patients)
SEROQUEL (16 patients)
AMITRIPTYLINE HYDROCHLORIDE (16 patients)
AMPICILLIN (16 patients)
ZOFRAN (16 patients)
VALIUM (15 patients)
CYANOCOBALAMIN (14 patients)
ALPRAZOLAM (14 patients)
WARFARIN SODIUM (14 patients)
VICODIN (14 patients)
ACYCLOVIR (13 patients)
LEVAQUIN (13 patients)
ROBAXIN (13 patients)
ALENDRONATE SODIUM (13 patients)
DECADRON (13 patients)
MORPHINE (13 patients)
VITAMIN B-12 (13 patients)
BACTRIM DS (13 patients)
ZELNORM (13 patients)
CIMZIA (13 patients)
ENTOCORT EC (13 patients)
ALTACE (12 patients)
VENTOLIN (12 patients)
K-DUR 10 (12 patients)
LEUCOVORIN CALCIUM (12 patients)
CYMBALTA (12 patients)
DEXAMETHASONE (12 patients)
MIRENA (12 patients)
GOLIMUMAB (12 patients)
HORMONES (UNSPECIFIED) (12 patients)
PREVACID (12 patients)
PRIMIDONE (12 patients)
CITALOPRAM HYDROBROMIDE (12 patients)
FENTANYL (12 patients)
VYTORIN (12 patients)
VITAMIN D (UNSPECIFIED) (11 patients)
ZOCOR (11 patients)
PREDNISOLONE (11 patients)
DOXORUBICIN HCL (11 patients)
POTASSIUM CHLORIDE (11 patients)
OYST CAL D (11 patients)
FAMOTIDINE (11 patients)
REGLAN (11 patients)
WELLBUTRIN (11 patients)
GABAPENTIN (11 patients)
OXYCODONE HCL (11 patients)
ZETIA (11 patients)
DULCOLAX (11 patients)
URBASON (11 patients)
CLOZARIL (11 patients)
CLONIDINE (11 patients)
RANITIDINE (11 patients)
REBIF (10 patients)
PREMPRO (10 patients)
YAZ (10 patients)
CLONOPIN (10 patients)
ESTRATEST (10 patients)
VITAMINS (10 patients)
ASCORBIC ACID (10 patients)
TOCILIZUMAB (10 patients)
DEPAKOTE (10 patients)
MIACALCIN (10 patients)
DOSTINEX (10 patients)
BACLOFEN (10 patients)
CELEXA (10 patients)
NITROSTAT (10 patients)
LANTUS (10 patients)
CALCIUM (10 patients)
DIFLUCAN (9 patients)
ENBREL (9 patients)
ONDANSETRON (9 patients)
TEGRETOL (9 patients)
PROMETHAZINE (9 patients)
INDAPAMIDE (9 patients)
ADVAIR DISKUS 100/50 (9 patients)
PLAVIX (9 patients)
LANSOPRAZOLE (9 patients)
TACROLIMUS (9 patients)
AMOXICILLIN (9 patients)
IMURAN (9 patients)
MULTI-VITAMINS (9 patients)
DIOVAN (9 patients)
MORPHINE SULFATE (9 patients)
CENTRUM (9 patients)
BIRTH CONTROL PILLS (9 patients)
ESTRADIOL (9 patients)
CALCIUM GLUCONATE (9 patients)
LUPRON DEPOT (9 patients)
FISH OIL (9 patients)
DICLOFENAC (9 patients)
CALCIUM CARBONATE (9 patients)
LOVENOX (8 patients)
MIRALAX (8 patients)
SALAGEN (8 patients)
CELECOXIB (8 patients)
ULTRAM (8 patients)
DEPO-PROVERA (8 patients)
TRAZODONE HCL (8 patients)
SK-ERYTHROMYCIN (8 patients)
MIRAPEX (8 patients)
VALTREX (8 patients)
TYLENOL (CAPLET) (8 patients)
YASMIN (8 patients)
RENAGEL (8 patients)
SERTRALINE HYDROCHLORIDE (8 patients)
CRESTOR (8 patients)
CARTICEL (8 patients)
AUGMENTIN '125' (8 patients)
DICLOFENAC SODIUM (8 patients)
AVASTIN (8 patients)
PENTASA (8 patients)
VELCADE (8 patients)
VANCOMYCIN (8 patients)
VINCRISTINE (8 patients)
PROGRAF (8 patients)
FLAGYL (8 patients)
UNCODEABLE ^UNCLASSIFIABLE^ (7 patients)
ELIDEL (7 patients)
FLOXIN OTIC (7 patients)
ACTOS (7 patients)
CLINDAMYCIN (7 patients)
IMIPRAMINE (7 patients)
OXALIPLATIN (7 patients)
AMITRIPTYLINE HCL (7 patients)
CIPROFLOXACIN (7 patients)
NIFEDIPINE (7 patients)
LAMICTAL (7 patients)
COZAAR (7 patients)
WARFARIN (7 patients)
FLORINEF (7 patients)
METOPROLOL (7 patients)
HUMALOG (7 patients)
BEVACIZUMAB (7 patients)
ISONIAZID (7 patients)
KLONOPIN (7 patients)
PROZAC (7 patients)
CALCICHEW (7 patients)
PYRIDIUM (7 patients)
RAMIPRIL (7 patients)
NUVARING (7 patients)
Most common side effects for patients taking CAPECITABINE:
DIARRHOEA (2587 patients)
VOMITING (1424 patients)
NAUSEA (1275 patients)
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME (1195 patients)
DEATH (1163 patients)
DEHYDRATION (1060 patients)
FATIGUE (751 patients)
PYREXIA (739 patients)
MALIGNANT NEOPLASM PROGRESSION (689 patients)
DISEASE PROGRESSION (688 patients)
NEUTROPENIA (604 patients)
DYSPNOEA (585 patients)
ABDOMINAL PAIN (584 patients)
MUCOSAL INFLAMMATION (556 patients)
PULMONARY EMBOLISM (539 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (527 patients)
ASTHENIA (518 patients)
ANAEMIA (469 patients)
DECREASED APPETITE (468 patients)
FEBRILE NEUTROPENIA (443 patients)
SEPSIS (430 patients)
THROMBOCYTOPENIA (389 patients)
MALAISE (387 patients)
INTESTINAL OBSTRUCTION (358 patients)
STOMATITIS (352 patients)
PNEUMONIA (341 patients)
NEUROPATHY PERIPHERAL (325 patients)
INFECTION (321 patients)
DIZZINESS (301 patients)
RENAL FAILURE (299 patients)
HYPOKALAEMIA (295 patients)
PAIN (289 patients)
HAEMOGLOBIN DECREASED (273 patients)
PLEURAL EFFUSION (269 patients)
HYPOTENSION (268 patients)
RENAL FAILURE ACUTE (258 patients)
PLATELET COUNT DECREASED (244 patients)
ASCITES (243 patients)
NEUTROPHIL COUNT DECREASED (242 patients)
BLOOD BILIRUBIN INCREASED (231 patients)
DEEP VEIN THROMBOSIS (225 patients)
HYPONATRAEMIA (224 patients)
CHEST PAIN (215 patients)
RASH (211 patients)
SEPTIC SHOCK (209 patients)
LEUKOPENIA (205 patients)
WEIGHT DECREASED (203 patients)
WHITE BLOOD CELL COUNT DECREASED (203 patients)
FALL (193 patients)
OEDEMA PERIPHERAL (192 patients)
ILEUS (186 patients)
PAIN IN EXTREMITY (182 patients)
HEADACHE (180 patients)
CONSTIPATION (177 patients)
ANOREXIA (176 patients)
RESPIRATORY FAILURE (176 patients)
GASTROINTESTINAL HAEMORRHAGE (175 patients)
ATRIAL FIBRILLATION (163 patients)
INTESTINAL PERFORATION (162 patients)
HYPERTENSION (162 patients)
ERYTHEMA (161 patients)
SMALL INTESTINAL OBSTRUCTION (158 patients)
SYNCOPE (154 patients)
PARAESTHESIA (154 patients)
CONFUSIONAL STATE (149 patients)
URINARY TRACT INFECTION (149 patients)
METASTASES TO LIVER (145 patients)
HEPATIC FAILURE (144 patients)
CEREBROVASCULAR ACCIDENT (144 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (143 patients)
BREAST CANCER METASTATIC (142 patients)
ABDOMINAL PAIN UPPER (136 patients)
CARDIAC ARREST (136 patients)
BACK PAIN (134 patients)
ALOPECIA (132 patients)
DYSPHAGIA (127 patients)
COLITIS (127 patients)
OSTEONECROSIS (126 patients)
BLOOD CREATININE INCREASED (126 patients)
CONVULSION (123 patients)
METASTASES TO CENTRAL NERVOUS SYSTEM (123 patients)
ABDOMINAL DISTENSION (120 patients)
CHILLS (120 patients)
IMPAIRED HEALING (120 patients)
NEOPLASM MALIGNANT (120 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (119 patients)
NEOPLASM PROGRESSION (119 patients)
MULTI-ORGAN FAILURE (117 patients)
THROMBOSIS (117 patients)
ALANINE AMINOTRANSFERASE INCREASED (114 patients)
GASTROINTESTINAL PERFORATION (110 patients)
DRUG INEFFECTIVE (110 patients)
PANCYTOPENIA (109 patients)
LOSS OF CONSCIOUSNESS (107 patients)
DRUG TOXICITY (107 patients)
SKIN EXFOLIATION (107 patients)
OEDEMA (106 patients)
ENTERITIS (106 patients)
HYPOAESTHESIA (106 patients)
CELLULITIS (105 patients)
SUDDEN DEATH (105 patients)
MYOCARDIAL INFARCTION (105 patients)
ANXIETY (103 patients)
PNEUMONIA ASPIRATION (103 patients)
CARDIAC FAILURE (102 patients)
SOMNOLENCE (102 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (99 patients)
HAEMATEMESIS (99 patients)
HYPERGLYCAEMIA (98 patients)
DRUG INTERACTION (97 patients)
METASTASES TO BONE (96 patients)
OESOPHAGITIS (94 patients)
METASTASES TO LUNG (92 patients)
LETHARGY (92 patients)
TACHYCARDIA (91 patients)
RECTAL HAEMORRHAGE (91 patients)
OVERDOSE (90 patients)
JAUNDICE (90 patients)
ARTHRALGIA (88 patients)
GAIT DISTURBANCE (86 patients)
TRANSIENT ISCHAEMIC ATTACK (85 patients)
PULMONARY OEDEMA (84 patients)
GASTROINTESTINAL TOXICITY (83 patients)
PALPITATIONS (83 patients)
HAEMORRHAGE (82 patients)
HEPATIC FUNCTION ABNORMAL (82 patients)
PROTEINURIA (82 patients)
INJECTION SITE EXTRAVASATION (82 patients)
PULMONARY ARTERY THROMBOSIS (80 patients)
HERPES ZOSTER (80 patients)
BLOOD SODIUM DECREASED (78 patients)
MUSCULAR WEAKNESS (77 patients)
INTERSTITIAL LUNG DISEASE (77 patients)
PERIPHERAL ISCHAEMIA (77 patients)
COUGH (76 patients)
GASTRITIS (76 patients)
HYPOXIA (76 patients)
HYPOPROTEINAEMIA (76 patients)
BREAST CANCER (75 patients)
DYSARTHRIA (75 patients)
PAIN IN JAW (75 patients)
HYPERSENSITIVITY (74 patients)
BONE DISORDER (73 patients)
HYPOALBUMINAEMIA (73 patients)
BONE PAIN (72 patients)
COMA (71 patients)
DYSGEUSIA (71 patients)
HAEMATOCRIT DECREASED (70 patients)
BLOOD POTASSIUM DECREASED (70 patients)
RENAL IMPAIRMENT (69 patients)
MENTAL STATUS CHANGES (69 patients)
METABOLIC ACIDOSIS (69 patients)
PNEUMOTHORAX (68 patients)
CONDITION AGGRAVATED (68 patients)
PERITONITIS (68 patients)
CEREBRAL INFARCTION (67 patients)
PERIPHERAL SENSORY NEUROPATHY (67 patients)
PANCREATITIS (67 patients)
BLOOD ALBUMIN DECREASED (66 patients)
HYPOPHAGIA (66 patients)
BLOOD PRESSURE INCREASED (66 patients)
HAEMATURIA (66 patients)
OSTEONECROSIS OF JAW (66 patients)
EPISTAXIS (66 patients)
CEREBRAL ISCHAEMIA (65 patients)
C-REACTIVE PROTEIN INCREASED (64 patients)
ILEUS PARALYTIC (64 patients)
LARGE INTESTINE PERFORATION (64 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (64 patients)
PNEUMONITIS (63 patients)
NEPHROTIC SYNDROME (63 patients)
DRY SKIN (62 patients)
TOOTH EXTRACTION (61 patients)
ANGINA PECTORIS (61 patients)
HYPERKALAEMIA (60 patients)
EPILEPSY (60 patients)
METASTASES TO SPINE (59 patients)
BLOOD PRESSURE DECREASED (59 patients)
BLOOD UREA INCREASED (58 patients)
NEUTROPENIC SEPSIS (57 patients)
NEUROTOXICITY (57 patients)
ABSCESS (57 patients)
JOINT SWELLING (57 patients)
MALNUTRITION (57 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (56 patients)
ATELECTASIS (56 patients)
FISTULA (55 patients)
DUODENAL ULCER (55 patients)
EJECTION FRACTION DECREASED (55 patients)
WOUND DEHISCENCE (55 patients)
ACUTE MYOCARDIAL INFARCTION (55 patients)
BLOOD GLUCOSE INCREASED (55 patients)
HEPATIC ENZYME INCREASED (55 patients)
SWELLING (55 patients)
PANCREATITIS ACUTE (54 patients)
ORAL INTAKE REDUCED (54 patients)
MELAENA (54 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (53 patients)
HYPERBILIRUBINAEMIA (53 patients)
TREMOR (53 patients)
CHOLELITHIASIS (53 patients)
BALANCE DISORDER (52 patients)
BLISTER (52 patients)
LUNG DISORDER (52 patients)
HEMIPARESIS (52 patients)
HEART RATE INCREASED (51 patients)
SKIN TOXICITY (51 patients)
GASTRIC PERFORATION (51 patients)
VISION BLURRED (50 patients)
RESPIRATORY DISORDER (50 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for CAPECITABINE


Issue Description / Topic Timestamp
QUESTION
GINGIVITIS
Can capcitabine cause gingivitis?what is its significance. My wife on capcitabine tablet complains of gingival pain. What is the treatment 2014-12-25 12:38:23
QUESTION
MUSCLE STRAIN
My husband has been on Xeloda for 16 weeks and has been really well. He is a golfer and hit 24 balls on the practice hoping to start his golf again. He complained of pain in his left breast after this. I wonder if it is because of his chemo. 2015-05-11 16:48:09
QUESTION
BURNING SENSATION
Burning sensation in a patient on capecitabine, what to do? 2015-05-26 14:22:39
QUESTION
BURNING SENSATION
Burning sensation in a patient on capecitabine, what to do? 2015-05-26 14:23:05
QUESTION
TESTICULAR PAIN
can zeloda cause scrotum pain and itching 2016-05-09 10:06:23
QUESTION
HYPERBARIC OXYGEN THERAPY
Are there any problems with a patient on Capecitabine having hyperbaric oxygen therapy? Thanks for your consideration. 2017-08-07 04:44:56
QUESTION
HYPERBARIC OXYGEN THERAPY
Are there any problems with a patient on Capecitabine having hyperbaric oxygen therapy? Thanks for your consideration. 2017-08-09 03:54:14

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about ADHESION and CAPECITABINE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking CAPECITABINE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in CAPECITABINE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for CAPECITABINE experts. If you are a healthcare provider experienced in prescribing CAPECITABINE, please register here.
giCould not connect: